Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled trial of Manpixiao Granules in chronic atrophic gastritis
CTR20263400Phase 2Active
- Sponsor
- Beijing University of Chinese Medicine
- Start
- Sep 2026
- Countries
- 1
01
Overview
A Phase 2 trial of Manpixiao Granules in atrophic gastritis (AG), sponsored by Beijing University of Chinese Medicine. Started Sep 2026; status: active.
02
Drugs
Manpixiao Granules
03
Conditions
atrophic gastritis (AG)
Beyond the preview
Go deeper on CTR20263400.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20263400.